Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

SIMPLE SUMMARY: Identifying which men at the time of prostate cancer diagnosis have, or will progress to, an aggressive fatal disease will allow clinicians to assist men in making better informed treatment decisions. This will not only be important for those men whose disease is likely to remain ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Dumont, Tú, Dowty, James G., MacInnis, Robert J., Steen, Jason A., Riaz, Moeen, Dugué, Pierre-Antoine, Renault, Anne-Laure, Hammet, Fleur, Mahmoodi, Maryam, Theys, Derrick, Tsimiklis, Helen, Severi, Gianluca, Bolton, Damien, Lacaze, Paul, Sebra, Robert, Schadt, Eric, McNeil, John, Giles, Graham G., Milne, Roger L., Southey, Melissa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036662/
https://www.ncbi.nlm.nih.gov/pubmed/33804961
http://dx.doi.org/10.3390/cancers13071495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036662/
https://www.ncbi.nlm.nih.gov/pubmed/33804961
http://dx.doi.org/10.3390/cancers13071495

Ejemplares similares